Seguridad de las terapias biológicas: nuevos datos de BIOBADASER-Reference-Cited by-同舟云学术

Seguridad de las terapias biológicas: nuevos datos de BIOBADASER

Published:2011-03 Issue: Volume:6 Page:1-6
ISSN:1699-258X
Container-title:Reumatología Clínica
language:es
Short-container-title:Reumatología Clínica

Author:

Rodríguez Lozano Carlos

Publisher

Elsevier BV

Subject

Rheumatology

Reference22 articles.

1. Comité Científico de BIOBADASER. BIOBADASER: Registro español de acontecimientos adversos de terapias biológicas en enfermedades reumáticas. Rev Esp Reumatol. 2002;29:292–99.

2. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology;Dixon;Ann Rheum Dis.,2010

3. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists;García-Doval;Ann Rheum Dis.,2010

4. Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience;Peña-Sagredo;Clin Exp Rheumatol.,2008

5. Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy;Peña-Sagredo;Clin Exp Rheumatol.,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Benefit of Perlingual Polybacterial Vaccines in Patients with Systemic Autoimmune Diseases and Active Immunosuppression;Biomedicines;2023-04-13

2. Sixth report of adverse events with biological treatments in Argentina. BIOBADASAR registry report;Revista Argentina de Reumatología;2019-03-01

3. Tuberculosis en pacientes inmunodeprimidos;Enfermedades Infecciosas y Microbiología Clínica;2018-06

4. Tuberculosis in immunosuppressed patients;Enfermedades infecciosas y microbiologia clinica (English ed.);2018-06

5. Biological Therapy and Neurological Manifestations. What do We Know?;Reumatología Clínica (English Edition);2017-03